...
首页> 外文期刊>Radiochimica Acta: International Journal for Chemical Aspects of Nuclear Science and Technology >Post-target produced [F-18]F-2 in the production of PET radiopharmaceuticals
【24h】

Post-target produced [F-18]F-2 in the production of PET radiopharmaceuticals

机译:PET放射性药物生产中的靶后生产[F-18] F-2

获取原文
获取原文并翻译 | 示例
           

摘要

Electrophilic radiofluorination was successfully carried out in the early years of PET radiochemistry due to its ease and fast reaction speed. However, at the present, the use of electrophilic methods is limited due to low specific activity (SA). Post-target produced [F-18]F-2 has significantly higher SA compared to other electrophilic approaches, and it has been used in the production of clinical PET radiopharmaceuticals at the Turku PET Centre for years. Here, we summarize the synthesis and use of these radiopharmaceuticals, namely [F-18]FDOPA, [F-18]CFT, [F-18]EF5 and [F-18]FBPA.
机译:由于它的易用性和快速的反应速度,PET放射化学的早期成功地进行了亲电子放射性氟化。然而,目前,由于低的比活(SA),亲电法的使用受到限制。与其他亲电子方法相比,靶后生产的[F-18] F-2具有显着更高的SA,并且已在Turku PET中心用于临床PET放射性药物的生产多年。在这里,我们总结了这些放射性药物,即[F-18] FDOPA,[F-18] CFT,[F-18] EF5和[F-18] FBPA的合成和使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号